Understanding the Lexicon of Fatigue in Parkinson's Disease.


Journal

Journal of Parkinson's disease
ISSN: 1877-718X
Titre abrégé: J Parkinsons Dis
Pays: Netherlands
ID NLM: 101567362

Informations de publication

Date de publication:
2020
Historique:
pubmed: 23 6 2020
medline: 16 9 2021
entrez: 23 6 2020
Statut: ppublish

Résumé

Fatigue in Parkinson's disease (PD) is multifaceted and associated with reduced quality of life. In turn, the language used by people with PD to describe fatigue is variable and poorly understood. We sought to elucidate the lexicon of fatigue using a qualitative grounded theory approach. The objective of this study was to understand how patients with PD describe fatigue. A pre-study phase of online journaling (Phase 1) provided information regarding topics of importance to patients. Following this, two independent samples of fatigued subjects were studied. Individuals with PD participated in a telephone interview (Phase 2); interview transcripts were analyzed to develop a detailed codebook. To ensure trustworthiness of the findings, an online survey (Phase 3) was administered to individuals with self-reported PD participating in the online study Fox Insight. The survey included the following question: "How do you define fatigue? Please provide your definition in the space below." The codebook developed from Phase 2 was applied to the Phase 3 responses. Fifteen individuals participated in Phase 2 and 413 individuals completed Phase 3. Fatigue was subdivided into three domains: cognitive, emotional, and physical. Nearly all individuals experienced more than one domain of fatigue. The most common themes included tiredness, lack of energy, and negative motivation. Fatigue in PD is multidimensional. Questionnaires that only assess the physical impact of fatigue may not be adequate to capture the broad range of experiences of fatigue among people with PD.

Sections du résumé

BACKGROUND
Fatigue in Parkinson's disease (PD) is multifaceted and associated with reduced quality of life. In turn, the language used by people with PD to describe fatigue is variable and poorly understood. We sought to elucidate the lexicon of fatigue using a qualitative grounded theory approach.
OBJECTIVE
The objective of this study was to understand how patients with PD describe fatigue.
METHODS
A pre-study phase of online journaling (Phase 1) provided information regarding topics of importance to patients. Following this, two independent samples of fatigued subjects were studied. Individuals with PD participated in a telephone interview (Phase 2); interview transcripts were analyzed to develop a detailed codebook. To ensure trustworthiness of the findings, an online survey (Phase 3) was administered to individuals with self-reported PD participating in the online study Fox Insight. The survey included the following question: "How do you define fatigue? Please provide your definition in the space below." The codebook developed from Phase 2 was applied to the Phase 3 responses.
RESULTS
Fifteen individuals participated in Phase 2 and 413 individuals completed Phase 3. Fatigue was subdivided into three domains: cognitive, emotional, and physical. Nearly all individuals experienced more than one domain of fatigue. The most common themes included tiredness, lack of energy, and negative motivation.
CONCLUSION
Fatigue in PD is multidimensional. Questionnaires that only assess the physical impact of fatigue may not be adequate to capture the broad range of experiences of fatigue among people with PD.

Identifiants

pubmed: 32568110
pii: JPD202029
doi: 10.3233/JPD-202029
pmc: PMC7458521
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1185-1193

Références

NPJ Parkinsons Dis. 2016;2:
pubmed: 27239558
J Parkinsons Dis. 2015;5(1):55-66
pubmed: 25624422
Qual Health Res. 2013 Jun;23(6):741-8
pubmed: 23515300
Curr Treat Options Neurol. 2009 May;11(3):186-90
pubmed: 19364453
Mov Disord. 2018 Nov;33(11):1712-1723
pubmed: 30264539
Parkinsonism Relat Disord. 2007 Oct;13(7):443-5
pubmed: 17055331
Acta Neurol Scand. 2017 Dec;136(6):570-584
pubmed: 28670681
J Geriatr Psychiatry Neurol. 1991 Jul-Sep;4(3):173-8
pubmed: 1953971
Int Rev Neurobiol. 2017;133:743-768
pubmed: 28802940
Sleep. 1991 Dec;14(6):540-5
pubmed: 1798888
Mov Disord. 2010 May 15;25(7):805-22
pubmed: 20461797
Sleep. 2003 Dec 15;26(8):1049-54
pubmed: 14746389
Sci Data. 2020 Feb 24;7(1):67
pubmed: 32094335
Sociol Health Illn. 2012 Jul;34(6):911-26
pubmed: 22443288
Qual Health Res. 2007 Dec;17(10):1372-80
pubmed: 18000076
J Parkinsons Dis. 2020;10(2):677-691
pubmed: 31958097
Qual Life Res. 2010 Oct;19(8):1087-96
pubmed: 20512662
Palliat Support Care. 2018 Aug;16(4):421-431
pubmed: 28660841
Parkinsonism Relat Disord. 2005 Jan;11(1):49-55
pubmed: 15619463
Parkinsonism Relat Disord. 2017 Oct;43:101-104
pubmed: 28751191
Mov Disord Clin Pract. 2020 Mar 05;7(3):284-292
pubmed: 32258226
Clin Neurol Neurosurg. 2018 Jun;169:12-15
pubmed: 29597014
J Neurol. 2012 Aug;259(8):1639-47
pubmed: 22237822
Psychogeriatrics. 2018 Mar;18(2):143-150
pubmed: 29409156
Mov Disord. 2016 May;31(5):625-31
pubmed: 26879133
Contemp Nurse. 2016 Dec;52(6):657-668
pubmed: 26394073

Auteurs

Sneha Mantri (S)

Department of Neurology, Duke University, Durham, NC, USA.

Emily Klawson (E)

Department of Behavioral and Community Health Sciences, University of Pittsburgh, Pittsburgh, PA, USA.

Steven Albert (S)

Department of Behavioral and Community Health Sciences, University of Pittsburgh, Pittsburgh, PA, USA.

Karina Nabieva (K)

The Edmond J Safra Program in Parkinson's disease, Toronto Western Hospital, University of Toronto, Toronto, Ontario, USA.

Madeline Lepore (M)

Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.

Stephen Kahl (S)

Tuck School of Business, Dartmouth College, Hanover, NH, USA.

Margaret Daeschler (M)

Michael J. Fox Foundation, New York, NY, USA.

Eugenia Mamikonyan (E)

Department of Psychiatry, University of Pennsylvania, Philadelphia, PA, USA.

Catherine Kopil (C)

Michael J. Fox Foundation, New York, NY, USA.

Connie Marras (C)

The Edmond J Safra Program in Parkinson's disease, Toronto Western Hospital, University of Toronto, Toronto, Ontario, USA.

Lana M Chahine (LM)

Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH